• Media type: E-Article
  • Title: Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study
  • Contributor: Sophie Vantyghem; Pierre Peterlin; Sylvain Thépot; Audrey Ménard; Viviane Dubruille; Camille Debord; Thierry Guillaume; Alice Garnier; Amandine Le Bourgeois; Soraya Wuilleme; Catherine Godon; Olivier Theisen; Marion Eveillard; Jacques Delaunay; Hervé Maisonneuve; Nadine Morineau; Bruno Villemagne; Stéphane Vigouroux; François Subiger; Elsa Lestang; Marion Loirat; Anne Parcelier; Pascal Godmer; Mélanie Mercier; [...]
  • imprint: Ferrata Storti Foundation (Haematologica), 2020
  • Published in: Haematologica
  • Language: Not determined
  • DOI: 10.3324/haematol.2019.242677
  • ISSN: 1592-8721; 0390-6078
  • Keywords: Hematology
  • Origination:
  • Footnote:
  • Description: <jats:p>Next-generation sequencing (NGS) is used to investigate the presence of somatic mutations. The utility of incorporating routine sequencing to guide diagnosis and therapeutic decisions remains unclear. We report the findings of an observational, multicenter study that aimed to assess the impact of somatic mutation testing by NGS in a reallife setting of chronic myeloid malignancies. A total of 177 patients were enrolled, partitioned into two overlapping groups. In group A (n=94), the indication was to search for clonal hematopoiesis, in a context of suspected myelodysplastic syndrome or myeloproliferative neoplasia. In group B (n=95), the theranostic impact of somatic mutations was studied. A panel of 34 genes was used on DNA extracted from blood or bone marrow samples. Within group A, the detection of clonal hematopoiesis supported the diagnosis of chronic myeloid malignancies for 31 patients while the absence of clonal hematopoiesis ruled out the suspected diagnosis in 47 patients. Within group B, NGS identified prognostically relevant somatic mutations in 32 patients, which had a therapeutic impact in 18 cases. By determining the presence or absence of somatic mutations, the application of NGS in daily practice was found to be useful for an integrated final diagnosis in 83% of the patients. Moreover, the search for somatic mutations had a prognostic impact that led to treatment modification in 19% of the cases. This study outlines the fact that adequate implementation of new investigations may have a significant positive medico-economic impact by enabling appropriate management of patients.</jats:p>
  • Access State: Open Access